Showing results (471-480 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|May 15, 2013
Safety evaluation of leflunomide in rheumatoid arthritisHelen I Keen, Philip G Conaghan, Susan E TettExpert Opinion on Drug Safety|May 15, 2013
2012 Annual Meeting of the Safety Pharmacology Society: spotlight on targeted oncology medicinesIcilio CaveroExpert Opinion on Drug Safety|October 7, 2014
Neoplasia following use of BMPs: is there an increased risk?Ippokratis Pountos, Michalis Panteli, Theodora Georgouli, et al.Expert Opinion on Drug Safety|September 23, 2014
Adjuvant systemic treatment for elderly breast cancer patients; addressing safety concernsOmar Abdel-Rahman, Hesham ElHalawaniExpert Opinion on Drug Safety|July 12, 2014
Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluationPiotr Rutkowski, Christian BlankExpert Opinion on Drug Safety|August 21, 2014
A safety evaluation of aripiprazole for treating schizophrenia during pregnancy and puerperiumSalvatore GentileExpert Opinion on Drug Safety|September 9, 2014
5-Hydroxytryptamine3 receptor antagonists and cardiac side effectsLouise Brygger, Jørn Herrstedt, Expert Opinion on Drug Safety|August 20, 2014
Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicityÁdám Jóna, Zsófia Miltényi, Zsófia Ujj, et al.Expert Opinion on Drug Safety|November 22, 2013
Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTCNicholas Moore, Francesco Salvo, Mai Duong, et al.Pageof 281